- Home
- RGC vs TBRG Comparison
RGC vs TBRG Comparison
Compare RGC & TBRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGC
- TBRG
- Stock Information
- Founded
- RGC 2014
- TBRG 1979
- Country
- RGC Hong Kong
- TBRG United States
- Employees
- RGC N/A
- TBRG N/A
- Industry
- RGC Medicinal Chemicals and Botanical Products
- TBRG
- Sector
- RGC Health Care
- TBRG
- Exchange
- RGC Nasdaq
- TBRG NYSE
- Market Cap
- RGC 171.1M
- TBRG 186.6M
- IPO Year
- RGC 2021
- TBRG N/A
- Fundamental
- Price
- RGC $5.60
- TBRG $11.95
- Analyst Decision
- RGC
- TBRG Buy
- Analyst Count
- RGC 0
- TBRG 2
- Target Price
- RGC N/A
- TBRG $13.50
- AVG Volume (30 Days)
- RGC 37.2K
- TBRG 57.4K
- Earning Date
- RGC 10-25-2024
- TBRG 11-06-2024
- Dividend Yield
- RGC N/A
- TBRG N/A
- EPS Growth
- RGC N/A
- TBRG N/A
- EPS
- RGC N/A
- TBRG N/A
- Revenue
- RGC N/A
- TBRG $336,557,000.00
- Revenue This Year
- RGC N/A
- TBRG $0.94
- Revenue Next Year
- RGC N/A
- TBRG $4.58
- P/E Ratio
- RGC N/A
- TBRG N/A
- Revenue Growth
- RGC N/A
- TBRG N/A
- 52 Week Low
- RGC $3.03
- TBRG $7.55
- 52 Week High
- RGC $32.44
- TBRG $17.28
- Technical
- Relative Strength Index (RSI)
- RGC 39.16
- TBRG 48.70
- Support Level
- RGC $5.52
- TBRG $11.77
- Resistance Level
- RGC $6.57
- TBRG $12.84
- Average True Range (ATR)
- RGC 0.78
- TBRG 0.40
- MACD
- RGC -0.28
- TBRG -0.10
- Stochastic Oscillator
- RGC 2.36
- TBRG 20.54
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.
About TBRG TRUBRIDGE INC
TruBridge Inc is a provider of healthcare solutions and services for community hospitals, clinics, and other healthcare systems. It provides services such as Electronic health records & information systems, revenue cycle management, population health, and data management, etc. The segments of the company are RCM, EHR, and Patient Engagement. The company derives maximum revenue from the RCM segment.